Advanced Curriculum for Multiple Sclerosis 2023

Advanced Curriculum for Multiple Sclerosis 2023

The 8th Annual Pre-ACTRIMS Comprehensive CME/CE Course

Date

Tuesday, February 21st, 2023 from 12:00pm – 6:30pm PT
Wednesday, February 22nd, 2023 from 8:00am – 12:00pm PT

Location

Marriott Marquis San Diego Marina
Marina Ballroom G
San Diego, CA

Registration

Dates

Tuesday, February 21st – Wednesday, February 22nd

Location

Marriott Marquis San Diego Marina
Marina Ballroom G
San Diego, CA

Overview

The 8th Annual Advanced Curriculum for Multiple Sclerosis, chaired by Dr. Fred D. Lublin, is an innovative, comprehensive medical education program that provides clinicians with recent information relative to all aspects of the multiple sclerosis disease spectrum. This comprehensive curriculum will utilize interactive lectures and patient case studies, among other formats, to deliver practical information regarding the care of patients with MS that can be applied into practice. Topics for this CME/CE course include diagnosis, biomarkers, monitoring, current and emerging MS therapeutics, shared decision making, management of the MS patient, and advances in MS centers.

Target Audience

Neurologists, MS specialists, fellows, residents, nurses, pharmacists, and other healthcare professionals involved in the management of patients with multiple sclerosis.

Agenda

*All timings are approximate and in Pacific Time 

Tuesday, February 21st, 2023
12:00pm–12:30pm Welcome and Introductions – Fred Lublin, MD
Multiple Sclerosis: Differential Diagnostics, Biomarkers and Monitoring
12:30pm – 12:55pm Update for Classification Diagnostic Criteria – Fred Lublin, MD
Patient Case with Interactive Panel: Initial Visit – New Patient in 2023
12:55pm – 1:20pm The Role of Biomarkers and Imaging for Diagnosis and Monitoring Disease Progression – Patricia Coyle, MD
Patient Case with Interactive Panel: Comprehensive MS Patient Workup
1:20pm – 1:45pm Accurate Alignment of Differential Diagnosis with Treatment Plans – Stephen Krieger, MD
Patient Case with Interactive Panel: Patient with 4-Year History of MS and Worsening Symptoms
1:45pm – 2:10pm Common Misdiagnoses – Lessons Learned – Joseph Berger, MD
Patient Case with Interactive Panel: MS Patient with 8-Year Delay in Diagnosis, Critical Opportunities Missed
2:10pm – 2:30pm Panel Discussion: Patricia Coyle, MD; Joseph Berger, MD; Stephen Krieger, MD
2:30pm – 3:00pm Break
3:00pm – 3:30pm Anti-CD19 Therapeutics to Manage Patients with Anti-AQP4 Antibody Positive Neuromyelitis Optic Spectrum Disorder – Hans Peter Hartung, MD
*Supported by an independent educational grant from Horizon Therapeutics
3:30pm – 5:10pm Clinical Trial Update – Review and Analysis of Current and Emerging MS Therapeutics

  • Cell Migration Inhibitors Peter Calabresi, MD
  • BTK Inhibitors – Benjamin Segal, MD
  • Immunomodulators Mark Freedman, MD
  • Cellular Depletion Therapeutics Mark Freedman, MD
  • New CD-20 Targeted Therapeutics – Mark Freedman, MD
    *Supported by an independent educational grant from TG Therapeutics
5:10pm – 5:30pm Panel Discussion: Mark Freedman, MD; Peter Calabresi, MD; Benjamin Segal, MD; Hans Peter Hartung, MD
5:30pm – 6:00pm Therapeutic Clinical Shared Decision Making: The Balance of Safety and Efficacy – Joseph Berger, MD
6:00pm – 6:30pm Continuing the Conversation: Addressing Unanswered Questions – Fred Lublin, MD

Wednesday, February 22nd, 2023
8:00am – 8:30am Welcome & Breakfast
Management of the MS Patient
8:30am – 8:55am Strategies to Preserve Cognitive Performance – Jack Antel, MD
8:55am – 9:20am Improved Strategies for Symptom Management June Halper, APN-C
9:20am – 9:45am COVID-19 Concerns & the MS Patient  Anne Cross, MD
9:45am – 10:10am Patient Management Decisions for Family Planning  Emmanuelle Waubant, MD, PhD
10:10am – 10:35am Advances in Healthcare Disparity Care for All MS Patients – Robert Naismith, MD
10:35am – 11:00am Panel Discussion: Emmanuelle Waubant, MD, PhD; Anne Cross, MD; Robert Naismith, MD; Jack Antel, MD; June Halper, APN-C
11:00am – 11:30am 2023: The New Era in MS Care – Advances in MS Centers – Clyde Markowitz, MD
11:30am – 12:00pm Final Thoughts: Looking to the Future – Fred Lublin, MD
Program Adjourns
The Advanced Curriculum for Multiple Sclerosis 2023 Course is supported by independent educational grants from Bristol-Myers Squibb, EMD Serono, Horizon Therapeutics, and TG Therapeutics

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Financial Support

This program is supported by independent educational grants from Bristol-Myers Squibb, EMD Serono, Horizon Therapeutics and TG Therapeutics.

Americans with Disabilities Act

Event Staff will be glad to assist you with any questions or special needs. Please contact AcademicCME at [email protected].

 _____________________________________________________

This activity is being held in conjunction with the ACTRIMS Forum 2023, from February 23rd to 25th in San Diego, CA.